PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study.

Abstract

PURPOSE:

PEGylated human hyaluronidase (PEGPH20) enzymatically depletes hyaluronan, an important component of the extracellular matrix, increasing the delivery of therapeutic molecules. Combinations of chemotherapy and PEGPH20, however, have been unsuccessful in Phase III clinical trials. We hypothesize that by increasing tumor oxygenation by improving vascular patency and perfusion, PEGPH20 will also act as a radiosensitization agent.

EXPERIMENTAL DESIGN:

The effect of PEGPH20 on radiation treatment was analyzed with respect to tumor growth, survival time, p02, local blood volume, and the perfusion/permeability of blood vessels in a human pancreatic adenocarcinoma BxPC3 mouse model overexpressing hyaluronan synthase 3 (HAS3).

RESULTS:

Mice overexpressing HAS3 developed fast growing, radiation resistant tumors that became rapidly more hypoxic as time progressed. Treatment with PEGPH20 increased survival times when used in combination with radiation therapy, significantly more than either radiation therapy or PEGPH20 alone. In mice that overexpressed HAS3, EPR imaging showed an increase in local pO2 that could be linked to increases in perfusion/permeability and local blood volume immediately after PEGPH20 treatment. Hyperpolarized [1-13C] pyruvate suggested PEGPH20 caused a metabolic shift towards decreased glycolytic flux. These effects were confined to the mice overexpressing HAS3 - no effect of PEGPH20 on survival, radiation treatment, or pO2 was seen in wild type BxPC3 tumors.

CONCLUSIONS:

PEGPH20 may be useful for radiosensitization of pancreatic cancer but only in the subset of tumors with substantial hyaluronan accumulation. The response of the treatment may potentially be monitored by non-invasive imaging of the hemodynamic and metabolic changes in the tumor microenvironment.

• Authors: Tomohiro Seki, Yu Saida, Shun Kishimoto, Jisook Lee, Yasunori Otowa, Kazutoshi Yamamoto, Gadisetti Vr Chandramouli, Nallathamby Devasahayam, James B Mitchell, Murali C Krishna, Jeffery R Brender
• Journal: Neoplasia (New York, N.Y.) (Neoplasia) Vol. 30 Pg. 100793 (08 2022) ISSN: 1476-5586 [Electronic] United States
• PMID: 35523073 (Publication Type: Journal Article)
• Copyright: Copyright © 2022. Published by Elsevier Inc.

Chemical References

• Polyethylene Glycols
• Hyaluronic Acid
• Hyaluronoglucosaminidase
• PEGPH20

Topics

• Adenocarcinoma (drug therapy)
• Animals
• Heterografts
• Humans
• Hyaluronic Acid (metabolism, pharmacology)
• Hyaluronoglucosaminidase (metabolism, pharmacology, therapeutic use)
• Mice
• Molecular Imaging
• Pancreatic Neoplasms (drug therapy, metabolism, radiotherapy)
• Polyethylene Glycols (pharmacology, therapeutic use)
• Tumor Microenvironment
• Pancreatic Neoplasms